ERNA vs SPGI · P/E 0.0, rev $582.0K vs P/E 27, rev $15.34B
Eterna Therapeutics Inc (ERNA) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the ERNA and SPGI stock pages for the full models.
Not investment advice.